Publication:
p19ARF Deficiency Disrupts Lung and Lipid Homeostasis Resembling the Human Alveolar Proteinosis.

dc.contributor.authorJimenez-Garcia, Lidia
dc.contributor.authorPérez-Montero, Andrea
dc.contributor.authorHerranz, Sandra
dc.contributor.authorLuque, Alfonso
dc.contributor.authorTarín, Carlos
dc.contributor.authorCastillo, Diego
dc.contributor.authorLopez-Vilaro, Laura
dc.contributor.authorMariñas-Pardo, Luis
dc.contributor.authorMcCarthy, Cormac
dc.contributor.authorAcebo, Paloma
dc.contributor.authorHortelano, Sonsoles
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderComunidad de Madrid (España)
dc.date.accessioned2026-03-31T11:02:27Z
dc.date.available2026-03-31T11:02:27Z
dc.date.issued2026-02-05
dc.description.abstractThe alternative reading frame (ARF) protein, encoded by the CDKN2A locus, is well-recognized for its role in tumor suppression. Emerging evidence has highlighted ARF as a critical regulator of innate immunity and inflammation, with links to increased susceptibility to cardio-metabolic diseases. This study investigates the role of ARF in lung homeostasis and reveals that its deficiency in mice affects lipid metabolism and leads to pulmonary abnormalities resembling pulmonary alveolar proteinosis (PAP). ARF-deficient mice exhibited abnormal surfactant clearance, characterized by lipid and protein accumulation in the alveoli, foamy alveolar macrophages (AMs) with enlarged and vacuolated morphology, and increased bronchoalveolar lavage fluid (BALF) turbidity. These changes were linked to disrupted surfactant homeostasis resulting from an imbalance between increased lipid uptake (via upregulation of scavenger receptors such as SR-A1 and CD36) and impaired lipid efflux, evidenced by reduced expression of the cholesterol transporter SR-BI. These mice also display reduced AMs numbers, increased eosinophil and neutrophil infiltration, consistent with secondary PAP. Additionally, a distinctive chemokine and cytokine profile (elevated Ccl12, Ccl2, Cxcl1, and IL10) was observed, which may be associated with type 2 immune responses and alternative AMs polarization. Interestingly, ARF deficiency also appears to compromise AMs maintenance through effects on self-renewal and survival. Pulmonary function tests revealed increased tissue elastance and damping, suggesting early-stage lung stiffness. Collectively, these findings highlight the essential role of ARF in lung homeostasis and lipid regulation, providing insights into its potential involvement in PAP pathogenesis.
dc.description.peerreviewed
dc.description.sponsorshipWe are grateful to Instituto de Salud Carlos III for financial support to S.H. (PI14.0055, PI17CIII/00012, PI20CIII/00018), A.L. (TPY-M-1068/13, IERPY 1149/16 and IERPY-M 389/18) and L.M-P (COOPERA Project, COOP24CIII/00009). L. Jiménez-Garcia was supported by FIS Page 24 of 68 Downloaded from https://academic.oup.com/ajrcmb/advance-article/doi/10.1093/ajrcmb/aanag003/8465564 by INSTITUTO DE SALUD CARLOS III user on 31 March 2026 (FI12/00340) and A. Pérez-Montero was supported by Comunidad de Madrid (PEJ-2020-AI/BMD17651).
dc.format.pageaanag003
dc.identifier.citationLidia Jiménez-Garcia, Andrea Pérez-Montero, Sandra Herranz, Alfonso Luque, Carlos Tarín, Diego Castillo, Laura Lopez-Vilaro, Luis Mariñas-Pardo, Cormac McCarthy, Paloma Acebo, Sonsoles Hortelano, p19ARF Deficiency Disrupts Lung and Lipid Homeostasis Resembling the Human Alveolar Proteinosis, American Journal of Respiratory Cell and Molecular Biology, 2026;, aanag003, https://doi.org/10.1093/ajrcmb/aanag003.
dc.identifier.doi10.1093/ajrcmb/aanag003
dc.identifier.journalAmerican Journal of Respiratory Cell and Molecular Biology
dc.identifier.pubmedID41738246
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27383
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III/Subprograma de proyectos de investigación en salud. Proyectos en salud/PI14CIII%2F00055//Estudio de la polarización de macrófagos en enfermedades intersticiales pulmonares. Búsqueda de biomarcadores e implementación de un nuevo modelo animal/
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia. Subprograma Estatal de Generación de Conocimiento. Proyectos de Investigacion en Salud Intramurales/PI17CIII%2F00012//La inflamación y los macrófagos como potenciales dianas en enfermedades intersticiales pulmonares. Estudio de nuevos reguladores y agentes terapéuticos./
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia. Subprograma Estatal de Generación de Conocimiento. Proyectos de Investigacion en Salud Intramurales/PI20CIII%2F00018//Estudio de la contribución de la microbiota, el metabolismo y la inmunidad innata a la aparición y progresión de las enfermedades pulmonares intersticiales./
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III//TPY-M-1068%2F13///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III//IERPY 1149%2F16///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III//IERPY-M 389%2F18///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III/COOPERA Project/COOP24CIII%2F00009///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Instituto de Salud Carlos III//FI12%2F00340///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Comunidad de Madrid//PEJ-2020-AI%2FBMD17651///
dc.relation.publisherversionhttps://doi.org/10.1093/ajrcmb/aanag003
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Raras (IIER)
dc.repisalud.institucionISCIII
dc.rights.accessRightsembargoed access
dc.subjectAlveolar macrophages
dc.subjectInflammatory profile
dc.subjectLipids
dc.subjectp19ARF
dc.subjectPulmonary alveolar proteinosis
dc.subjectPulmonary surfactant
dc.titlep19ARF Deficiency Disrupts Lung and Lipid Homeostasis Resembling the Human Alveolar Proteinosis.
dc.typeresearch article
dc.type.hasVersionAM
dspace.entity.typePublication
relation.isAuthorOfPublicationad7d13b5-f651-4427-8b3c-dc5a490a26d0
relation.isAuthorOfPublication12974951-091d-40de-93a8-d17ffddbb7d2
relation.isAuthorOfPublicationd137e820-b2a3-461d-947b-ae848370c7a4
relation.isAuthorOfPublicationca105c93-39d6-4234-be3f-018574636411
relation.isAuthorOfPublicationd810181a-24a5-476a-8e22-4d74c88c75e2
relation.isAuthorOfPublicatione8434c4f-9d6e-418c-ba38-a3728163d52b
relation.isAuthorOfPublication.latestForDiscoveryad7d13b5-f651-4427-8b3c-dc5a490a26d0
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication465a0b1e-d9df-4342-b738-86ffcafc4bcf
relation.isPublisherOfPublication.latestForDiscovery465a0b1e-d9df-4342-b738-86ffcafc4bcf

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
p19ARF_DeficiencyDisruptsLung_2026.pdf
Size:
1.86 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary_p19ARF_DeficiencyDisruptsLung_2026.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format